Biological and reagent material

Ended Awarded

Contract number
75N91024F90073
Awardee
Awarding agency
Obligated
$24,339

Award facts

Contract value 100% obligated
$24,339.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
339999 All Other Miscellaneous Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98119, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a $24,339.03 firm fixed-price blanket purchase agreement (BPA) call to Nanostring Technologies, Inc. for biological and reagent materials. The contract was executed on April 23, 2024, with an ultimate completion date of May 22, 2024, and is being performed in Seattle, Washington. This award carries no set-aside designation and represents a call against an existing BPA vehicle, allowing the government to procure specialized genomic analysis reagents and consumables from Nanostring's product portfolio to support the National Cancer Institute's research initiatives.

Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools specializing in multiplexed digital detection technologies, including the nCounter Analysis Systems and GeoMx Digital Spatial Profiler. The company has an extensive history supplying reagents, assays, and laboratory equipment to federal agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense. Nanostring currently holds significant federal contract vehicles, including a $2.8 million blanket purchase agreement with the Defense Health Agency through August 2026 and a $596,881.45 single-award indefinite delivery/indefinite quantity contract with the USDA Agricultural Research Service through April 2028, demonstrating the company's established relationship with the federal government for genomic research support.

Quick answers

Who was awarded contract 75N91024F90073?

75N91024F90073 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on April 23, 2024.

How much is contract 75N91024F90073 worth?

The government has obligated $24,339 on 75N91024F90073.

Is contract 75N91024F90073 an order under another contract?

Yes. 75N91024F90073 is a BPA call under HHSN263201400050B, a blanket purchase agreement.

Was contract 75N91024F90073 competed?

The extent of competition for 75N91024F90073 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award